BioCardia CEO Peter Altman acquires common shares worth $3,749.80

• BioCardia President, CEO, director Peter Altman bought 4,300 common shares in open-market purchases at weighted-average prices of $0.88, $0.86.
• Altman’s direct holding rose to 368,385 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-023637), on July 15, 2026, and is solely responsible for the information contained therein.